Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-09

Clinical Trial Update: NeoSync TMS Treatment for Bipolar I Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update for NeoSync TMS treatment in bipolar depression has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeoSync TMS

Snippet

Sponsor: Butler Hospital | Conditions: Major Depressive Episode, Bipolar Depression | Phase 2 | Status: TERMINATED | Results posted: 2020-04-09